Lehrstuhl für Innere Medizin III

SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL (2020) Baraliakos X, Gossec L, Pournara E, Jeka S, Blanco R, D'Angelo S, Schett G, et al. Conference contribution LONGITUDINAL CHANGE IN THE CENTRAL NERVOUS SYSTEM PAIN RESPONSE AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO. A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Rech J, Tascilar K, Schenker H, Hagen M, Sergeeva M, Selvakumar M, Konerth L, et al. Conference contribution GENDER DIFFERENCES IN PSA OUTCOME PARAMETERS AND THEIR CORRELATION WITH SKIN INVOLVEMENT: A CROSS-SECTIONAL ANALYSIS OF RABBIT-SPA PATIENTS (2020) Regierer A, Weiss A, Behrens F, Feuchtenberger M, Schett G, Baraliakos X, Zink A, Strangfeld A Conference contribution VASCULARIZED THREE-DIMENSIONAL MODELS OF HUMAN SKIN FIBROSIS (2020) Matei AE, Chen CW, Kiesewetter L, Györfi AH, Li YN, Trinh-Minh T, Van Kuppevelt T, et al. Conference contribution REAL-WORLD EFFECTIVENESS AND PERCEIVED USEFULNESS OF SYMPTOM CHECKERS IN RHEUMATOLOGY: INTERIM REPORT FROM THE PROSPECTIVE MULTICENTER BETTER STUDY (2020) Knitza J, Mohn J, Bergmann C, Kampylafka E, Hagen M, Bohr D, Araujo E, et al. Conference contribution MICROBIOTA-INDUCED INTESTINAL BARRIER DYSFUNCTION PRECEDES THE ONSET OF ARTHRITIS AND ALLOWS THE SHUTTLING OF IMMUNE CELLS FROM THE GUT THE JOINTS (2020) Zaiss M, Taijc N, Sarter K, Azizov V, Bucci L, Luo Y, Canete JDD, et al. Conference contribution NO INCREASED RISK OF FALLS IN PATIENTS TREATED WITH BIOLOGICS COMPARED TO THOSE UNDER CSDMARDS (2020) Rudi T, Schaefer M, Manger B, Zink A, Strangfeld A Conference contribution FIBROBLAST GROWTH FACTOR RECEPTOR 3 REGULATES THE ACTIVITY OF PROFIBROTIC CYTOKINE AND GROWTH FACTOR PATHWAYS TO DRIVE FIBROBLAST ACTIVATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS (2020) Chakraborty D, Zhu H, Juengel A, Summa L, Li YN, Bergmann C, Matei AE, et al. Conference contribution ADAPTOR PROTEINS ACTIVATE FIBROBLASTS IN SYSTEMIC SCLEROSIS (2020) Ariza Y, Weber S, Neise N, Kreuter A, Schett G, Distler J, Ramming A Conference contribution INNATE LYMPHOID CELLS INDUCE A FIBROTIC PHENOTYPE OF FIBROBLASTS (2020) Weber S, Anchang CG, Rauber S, Luber M, Raimondo MG, Ariza Y, Rigau AR, et al. Conference contribution